{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:00Z","timestamp":1790266860892,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22YF1449600"],"award-info":[{"award-number":["22YF1449600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of The Peoples Republic of China","doi-asserted-by":"publisher","award":["ZYYZDXK-2023060"],"award-info":[{"award-number":["ZYYZDXK-2023060"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370582"],"award-info":[{"award-number":["82370582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.livres.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T19:12:53Z","timestamp":1744744373000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rhizoma Atractylodis Macrocephalae reduces HFD-induced MAFLD in mice through activated AMPK-mediated inhibition of fatty acid synthesis"],"prefix":"10.1016","volume":"9","author":[{"given":"Ke","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2025.04.004_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.livres.2025.04.004_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.livres.2025.04.004_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.livres.2025.04.004_bib4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.livres.2025.04.004_bib5","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.22","article-title":"Clinical management of non-alcoholic steatohepatitis and the role of the cardiologist","volume":"18","author":"Mill\u00e1n-Rodr\u00edguez","year":"2023","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.livres.2025.04.004_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.004_bib7","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.004_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.004_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.livres.2023.08.005","article-title":"Non-alcoholic fatty liver disease: dietary and nutraceutical approaches","volume":"7","author":"Cogorno","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2025.04.004_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphar.2020.00601","article-title":"Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application","volume":"11","author":"Xu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib11","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1097\/CM9.0000000000003355","article-title":"Drug treatment for metabolic dysfunction-associated steatotic liver disease: progress and direction","volume":"137","author":"Zhou","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.livres.2025.04.004_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00204-014-1263-1","article-title":"Metformin aggravates immune-mediated liver injury in mice","volume":"89","author":"Volarevic","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.livres.2025.04.004_bib13","article-title":"Paternal metformin use and congenital malformations in offspring","volume":"387","author":"Gordon","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.livres.2025.04.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115743","article-title":"Metformin derivatives - researchers\u2019 friends or foes?","volume":"215","author":"Torunoglu","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib15","article-title":"Literature review of the clinical characteristics of metformin-induced hepatotoxicity","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib16","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/MJT.0000000000000007","article-title":"Metformin as a rare cause of drug-induced liver injury, a case report and literature review","volume":"23","author":"Zheng","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.livres.2025.04.004_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13020-024-00894-1","article-title":"Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies","volume":"19","author":"Ding","year":"2024","journal-title":"Chin Med"},{"key":"10.1016\/j.livres.2025.04.004_bib19","article-title":"A review of the ethnopharmacology, phytochemistry, pharmacology, application, quality control, processing, toxicology, and pharmacokinetics of the dried rhizome of Atractylodes macrocephala","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/643654","article-title":"The roots of Atractylodes macrocephala koidzumi enhanced glucose and lipid metabolism in C2C12 myotubes via mitochondrial regulation","volume":"2015","author":"Song","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.livres.2025.04.004_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010278","article-title":"The root of Atractylodes macrocephala Koidzumi prevents obesity and glucose intolerance and increases energy metabolism in mice","volume":"19","author":"Song","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.04.004_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22111886","article-title":"Atractylenolide II inhibits proliferation, motility and induces apoptosis in human gastric carcinoma cell lines HGC-27 and AGS","volume":"22","author":"Tian","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.livres.2025.04.004_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joim.2020.04.005","article-title":"Suppressive effect of Aurantii Fructus Immaturus and Atractylodis Macrocephalae Rhizoma on glutamic acid-induced autophagy of interstitial cells of Cajal","volume":"18","author":"Yan","year":"2020","journal-title":"J Integr Med"},{"key":"10.1016\/j.livres.2025.04.004_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1496639","article-title":"Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond","volume":"15","author":"Tai","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2025.04.004_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbrc.2009.11.029","article-title":"Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK","volume":"391","author":"Cho","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2025.04.004_bib27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.livres.2025.04.004_bib28","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.livres.2025.04.004_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.livres.2025.04.004_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/ac302919t","article-title":"Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: when less is more","volume":"85","author":"Tulipani","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.livres.2025.04.004_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.livres.2025.04.004_bib32","first-page":"256","article-title":"High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL\/6j mice","volume":"7","author":"van der Heijden","year":"2015","journal-title":"Aging (Albany N Y)"},{"key":"10.1016\/j.livres.2025.04.004_bib33","first-page":"323","article-title":"Network pharmacology approaches for research of Traditional Chinese Medicines","volume":"21","author":"Li","year":"2023","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.livres.2025.04.004_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115876","article-title":"Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation","volume":"302","author":"Shang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","article-title":"Lipid disorders and metabolic-associated fatty liver disease","volume":"52","author":"Anwar","year":"2023","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.livres.2025.04.004_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.livres.2025.04.004_bib38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.livres.2025.04.004_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2024.08.038","article-title":"Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1","volume":"224","author":"Zhang","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2025.04.004_bib40","first-page":"955","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2025.04.004_bib41","article-title":"Quantitative proteomics reveals Polygonum perfoliatum L. ameliorates hepatic steatosis by promoting PPARs\/CPT1A\/CPT2-mediated fatty acid \u03b2-oxidation","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib42","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.3748\/wjg.v25.i34.5105","article-title":"Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease","volume":"25","author":"Yang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2025.04.004_bib43","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.biopha.2018.03.158","article-title":"Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2025.04.004_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9701285","article-title":"Prevention of nonalcoholic hepatic steatosis by Shenling Baizhu powder: involvement of adiponectin-induced inhibition of hepatic SREBP-1c","volume":"2020","author":"Tang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.livres.2025.04.004_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1147067","article-title":"Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice","volume":"14","author":"Yao","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.livres.2025.04.004_bib46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.joim.2021.07.004","article-title":"Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4\/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease","volume":"19","author":"Pan","year":"2021","journal-title":"J Integr Med"},{"key":"10.1016\/j.livres.2025.04.004_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.livres.2025.04.004_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116988","article-title":"The identification of material basis of Si Miao Formula effective for attenuating non-alcoholic fatty liver disease","volume":"318","author":"Li","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1017\/S0007114511002753","article-title":"Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress","volume":"107","author":"G\u00f3mez-Zorita","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.livres.2025.04.004_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fphar.2020.00351","article-title":"The impacts of herbal medicines and natural products on regulating the hepatic lipid metabolism","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.004_bib51","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.livres.2025.04.004_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120732","article-title":"The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: new insights and future directions","volume":"305","author":"Alshehade","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2025.04.004_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156026","article-title":"Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease","volume":"135","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.livres.2025.04.004_bib54","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.apsb.2024.05.014","article-title":"Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm Sin B"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:21:45Z","timestamp":1762629705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568425000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2542568425000297"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2025.04.004","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhizoma Atractylodis Macrocephalae reduces HFD-induced MAFLD in mice through activated AMPK-mediated inhibition of fatty acid synthesis","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}